Ipsen, GENFIT Reveal Positive Phase III Trial Results Of Elafibranor In Patients With PBC
30/6 07:58
(RTTNews) - French pharmaceutical company Ipsen SA (IPSEY) and late-stage biopharmaceutical company GENFIT SA (GNFT) announced Friday positive topline data from the pivotal ELATIVE Phase III trial of elafibranor in patients with primary biliary cholangitis or PBC, a rare cholesta...